GAVIN Sathianathan, a founder member of Oxford Cannabinoid Technologies (OCT), published a bombshell letter to fellow investors last week laying
Oxford Cannabinoid Technologies (OCT) has seen its second senior departure in under a month as it begins to recover from
LONDON Stock Exchange debutant Oxford Cannabinoid Technologies is aiming to emulate the success of GW Pharmaceuticals. Its founders Gavin Sathianathan
BIOTECH company Oxford Cannabinoid Technologies to float on the London Stock Exchange in a listing which is set to value
DESPITE the United Nations recently recognising the medical benefits of cannabis, an influential global body says there is insufficient evidence
THE NHS is to launch is first-ever cannabis patient registry in a move which signifies an ambition for the medicines
NEW Government figures show a 900% increase in the number of cannabis medicines notified for import demonstrating the private sector’s
SECURING patient-generated data and enabling them to speak the language of the health-care system is at the heart of a
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
